This guide explores ASX penny stocks, including their risks and opportunities, trading tips, and five promising shares to watch in 2026.
This article is for informational purposes only and does not constitute investment or trading advice. Please ensure you understand the risks and consider your individual circumstances before trading.
In Australia, many classify penny stocks as those under one Australian dollar per share, while some use the definition loosely to describe any company with smaller share prices.
Penny stock share trading requires a high degree of due diligence, as they represent smaller propositions that usually come with a far higher risk-to-reward ratio. Ensure you have adequate risk management in place before you consider trading penny stocks.
It’s also worth noting that penny stocks can have high market caps if a large number of shares have been issued.
ASX penny stocks are often thinly traded. This means that, unlike the blue-chip shares of the ASX 200, where every stock usually has a wall of potential buyers, there might not always be enough buyer demand when share traders want to sell.
In addition, penny stocks are often loss-making, using any money available to invest in growth. This makes them highly speculative investments. Moreover, they usually receive little to no analyst coverage, making informed trading decisions difficult.
They can also even lack in-depth trading records. And some penny stocks are notorious for diluting stock value by issuing additional shares.
These risk factors mean that for most share traders, penny stocks should only form a small percentage of their portfolio. And for those closer to retirement who are investing over short timeframes, they arguably should be avoided altogether.
Of course, despite these significant risks, ASX penny stocks hold a unique advantage. The right pick can be massively more lucrative than an investment in more established peers.
However, it’s important to be aware of the echo chamber of success. Skyrocketing penny stocks are extremely likely to hit mainstream news, but the success stories are significantly outnumbered by the failures. Moreover, once an ASX penny stock hits the headlines, it's often too late to partake in its success.
But many of the largest blue-chip stocks on the ASX began trading as penny stocks. For example, one of the largest stocks on the ASX, BHP, used to be a penny stock back in 1999. Afterpay was a penny stock as recently as 2017. International market titans Apple and Amazon also once qualified as penny stocks for share traders with the foresight and luck to invest early.
We selected these penny stocks based on three main factors:
All the penny stocks on our list are available for share trading with us, while Prescient Therapeutics, EDU Holdings and Predictive Discovery are available to CFD trade with us.
All figures are accurate as of 15 May 2026.
Company |
Sector |
Share price |
Market cap |
Trade the share CFD with us? |
Share trade the stock with us? |
Non-energy minerals |
A$0.400
|
A$160.61 million1 |
X |
✓ |
|
Health technology |
A$0.065 |
A$72.55 million2 |
✓ |
✓ |
|
Commercial services |
A$0.870 |
A$106.14 million3 |
✓ |
✓ |
|
Process industries |
A$0.540 |
A$64.03 million4 |
X |
✓ |
|
Non-energy minerals |
A$0.930 |
A$4.92 billion5 |
✓ |
✓ |
Sector: Non-energy minerals
Market cap: A$160.61 million
Share price: A$0.400
Atomic Eagle is a junior exploration company focused on uncovering high-value mineral deposits, primarily within the gold and critical minerals sectors. It typically operates in mining-friendly jurisdictions like Western Australia, where it seeks to identify and develop projects that have been overlooked or under-explored by larger industry players.
Its business model revolves around the high-risk, high-reward cycle of drill-and-discover, where a single successful exploration campaign can fundamentally revalue the business.
Over the past six months, Atomic Eagle has focused on refining its geological targets through advanced geophysical surveys and soil sampling. It recently announced the commencement of a fresh diamond drilling programme at its flagship project to test deeper extensions of known mineralised zones.
Early visual observations from these cores have been encouraging for the geological team, prompting the business to secure additional land holdings in the surrounding area to bolster its exploration footprint.
Suitability:
Risk factors:
Sector: Health technology
Market cap: A$72.55 million
Share price: A$0.065
Prescient Therapeutics is a clinical-stage oncology company developing a new generation of personalised cancer treatments. Its primary focus is on CAR-T and targeted therapies designed to treat various cancers that are resistant to traditional medicine. Its OmniCAR platform is particularly notable as it aims to give clinicians greater control over cell therapies, potentially making treatments safer and more effective for patients.
The last six months have been pivotal as Prescient advanced its clinical trials for various blood cancers. It reported positive safety data from its latest patient cohorts, which allowed it to move into higher-dosing phases of its studies. Furthermore, it has been active in the global biotech community, presenting its findings at international conferences and expanding its intellectual property portfolio through new patent filings in major markets.
Suitability:
Risk factors:
Sector: Commercial services
Market cap: A$106.14 million
Share price: A$0.870
EDU Holdings operates in the education sector, specifically focusing on tertiary and vocational training. It owns and manages several private education providers that cater to both domestic and international students. Its revenue is largely driven by student enrolments and the delivery of accredited courses ranging from business and health to creative industries. It aims to capitalise on the demand for skilled workers in the Australian economy.
In the previous half-year, EDU Holdings has navigated a shifting landscape for international student visas in Australia. Despite broader regulatory changes, it has seen resilient enrolment numbers in its core vocational health programmes.
Management has also been focused on a digital-first expansion, investing in online learning infrastructure to reach students who cannot attend physical campuses, which has helped diversify its income streams.
Suitability:
Risk factors:
Sector: Process industries
Market cap: A$64.03 million
Share price: A$0.540
Laserbond is an industrial technology company specialising in surface engineering. It uses high-tech laser cladding and thermal spraying to coat machinery parts with ultra-hard materials, making them last much longer in harsh environments like mining and heavy manufacturing. It also manufactures the specialised equipment used for these processes, selling its proprietary technology to international clients.
Recent months have seen Laserbond expanding its physical footprint, with a focus on increasing its capacity in Western Australia to better serve the resources sector. It has secured several new long-term maintenance contracts with major mining houses, providing a steady stream of recurring revenue.
Suitability:
Risk factors:
Sector: Non-energy minerals
Market cap: A$4.92 billion
Share price: A$0.930
Predictive Discovery is a gold exploration company with its sights set on West Africa. Its primary asset is the Bankan Gold Project in Guinea, which has already shown signs of being a Tier-1 resource.
Unlike an early-stage explorer, Predictive has already defined a massive gold resource and is now working through the technical and environmental studies required to turn the site into an operating mine.
The past six months have been dominated by the progress of the Definitive Feasibility Study (DFS) for the Bankan project. It has consistently released updates regarding its environmental and social impact assessments, which are crucial for securing a mining licence.
Suitability:
Risk factors:
This is the idea that if a share price falls between 7% and 8% below what you paid for it, you should sell it.
If a company keeps spending more than it earns, and share traders sell their shares, theoretically, a stock’s price can hit 0.
Some analysts recommend buying a substantial number of a penny stock’s shares – its low price means the full investment won’t total too much, but if the value increases, the shareholding can grow substantially. Of course, this is a risky strategy, as is any when purchasing penny stocks, as these are high-risk, high-reward shares.
This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.